A MInT study comparing CHOP to R-CHOP is one of few prospective trials recruiting PMBCL patients, who constituted 11 % (n = 87) of all 824 DLBCL patients [45••]. The gene discussed is DDIT3; the disease is diffuse large B-cell lymphoma.